Upload Avatar (500 x 500)
Pingping Fang
pingpingfang@whu.edu.cn
English, Chinese
Hubei
Wuhan University
Medical School
  • 2013.08-2018.05 PhD in Pharmacology, University of Kansas Medical Center, USA
  • 2008.09-2010.06 Master in Biochemistry and Molecular Biology, Wuhan University, China
  • 2004.09-2008.06 Bachelor in Biotechnology, Weifang University, China
  • 2020.01-present Distinguished Associate Researcher, Department of Pharmacology, School of Basic Medical Sciences, Wuhan University
  • 2018.07-2018.12 Postdoctoral Fellow, Comprehensive Cancer Center, University of New Mexico, USA
  • 2017.08-2018.06 Visiting Scholar, Comprehensive Cancer Center, University of New Mexico, USA
  • 2013.08-2017.08 Teaching and Research Assistant, University of Kansas Medical Center, USA
  • 2011.11-2013.08 Laboratory Technician, Stowers Institute for Medical Research, USA
  • 2010.07-2011.06 Research Assistant, College of Life Sciences, Wuhan University, China
Development of genomic and proteomic research methods
Study of drug resistance in targeted therapies and exploration of new targeted treatment strategies
  • CDK12 and Integrator-PP2A Complex Modulates LEO1 Phosphorylation for Processive Transcription Elongation, Qiu M., Yin Z., Wang H., Lei L., Li C., Cui Y., Dai R., Yang P., Xiang Y., Li Q., Lv J., Hu Z., Chen M., Zhou H., Fang, P.*, Xiao R.*, Liang K.*, 2023
  • G-quadruplexes sense natural porphyrin metabolites for regulation of gene transcription and chromatin landscapes, Li C., Yin Z., Xiao R., Huang B., Cui Y., Wang H., Xiang Y., Wang L., Lei L., Ye J., Li T., Zhong Y., Guo F., Xia Y., Fang P.*, Liang K.*, 2022
  • Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer, X. Deng, B. Xie, Q. Li, Y. Xiao, Z. Hu, X. Deng, P. Fang*, C. Dong*, H. Zhou*, J. Huang*, 2022
  • Ligand-induced Native G-quadruplexes Stabilization Impairs Transcription Initiation, C. Li, H. Wang, Z. Yin, P. Fang, R. Xiao, Y. Xiang, W. Wang, Q. Li, B. Huang, J. Huang, K. Liang*, 2021
  • Genomic Profiling of Native R-loops with a DNA-RNA Hybrid Recognition Sensor, K. Wang, H. Wang, C. Li, Z. Yin, R. Xiao, Q. Li, Y. Xiang, W. Wang, J. Huang, L. Chen, P. Fang, K. Liang*, 2021
  • Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor alpha antagonism, J. Wu, J. Yan, P. Fang, H.B. Zhou, K. Liang, J. Huang*, 2020
  • Genome-scale CRISPR knockout screen identifies TIGAR as a modifier of PARP inhibitor sensitivity, Fang, P., De Souza, C., Minn, K., Chien, J*., 2019
  • Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition, Fang, P., Madden, J.A., Neums, L., Moulder, R.K., Forrest, M.L., Chien, J*., 2018
Genomics Proteomics Research Methods Drug Resistance Targeted Therapies Treatment Strategies Dna Damage Gene Transcription Regulation Inhibitors

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.